November 7, 2019 Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Collaborates with Owlstone Medical to Advance the Identification of Novel Biomarkers

Thermo Fisher Scientific Collaborates with Owlstone Medical to Advance the Identification of Novel Biomarkers Early disease detection enabled through discovery of biomarkers using non-invasive breath biopsy SAN JOSE, Calif., Nov. 7, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Owlstone Medical, the global leader in Breath Biopsy for applications in... Read more

November 6, 2019 M&A, Partnerships

Promega Enters Global Collaboration with Merck to Develop Microsatellite Instability (MSI) Companion Diagnostic for Use with KEYTRUDA®

Madison, WI USA. (November 6, 2019) Promega Corporation today announced it has entered into a global collaboration with Merck, known as MSD outside the United States and Canada, to develop Promega’s microsatellite instability (MSI) technology as an on-label, solid tumor companion diagnostic (CDx) for use with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab). The global collaboration will initially... Read more

October 31, 2019 M&A, Partnerships

AMETEK Completes Acquisition of Gatan

Thursday, October 31, 2019 BERWYN, Pa. and SARASOTA, Fla. (October 31, 2019) – AMETEK, Inc. (NYSE: AME) today announced that it has completed its acquisition of Gatan, a leading manufacturer of instrumentation and software used to enhance and extend the operation and performance of electron microscopes. AMETEK acquired Gatan from Roper Technologies, Inc. (NYSE: ROP)... Read more

October 30, 2019 Acad, Gov/Utilities M&A, Partnerships

ZEISS and Kyoto University consolidate strategic partnership

New ZEISS iCeMS Innovation Core collaborative laboratory opened Topics Press Release About ZEISS Press Photos Further Articles Jena/Germany, Kyoto/Japan | 30 October 2019 | ZEISS Research Microscopy Solutions ZEISS and Kyoto University are intensifying their cooperation and have signed a new strategic research agreement. As part of the agreement, the partners are opening the ZEISS iCeMS... Read more

October 21, 2019 Bio/Pharma/CRO Environ, Ag./Food & Bev Lab Top-10 M&A, Partnerships

Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process

Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process WASHINGTON, Oct. 21, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to... Read more

October 10, 2019 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing

MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform 10 OCT 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Acquisition of FloDesign Sonics marks next step in autologous manufacturing  MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts,  developer of a unique acoustic cell processing platform for... Read more

October 9, 2019 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer

Theragnostics’ novel PET tracer, GalliProst, will help visualize prostate cancer to enable personalized treatment. The two companies will leverage their combined scientific, commercial and market access expertise to work towards a commercial launch. Chalfont St Giles, UK – October 9th 2019 – GE Healthcare and Theragnostics have entered into a global commercial partnership for a... Read more

October 7, 2019 Bio/Pharma/CRO M&A, Partnerships PR/Corporate

vertX Bioprocess Conference Convenes Biotech and Biopharma Leaders to Accelerate Industry Collaboration

vertX Bioprocess Conference Convenes Biotech and Biopharma Leaders to Accelerate Industry Collaboration Thermo Fisher Scientific’s forum focuses on strategies to expedite biotherapeutic development and commercialization LOGAN, Utah, Oct. 7, 2019 /PRNewswire/ — To discuss the future strategies of biologics development and commercialization, Thermo Fisher Scientific hosted the inaugural vertX Bioprocess Conference on Thursday, September 26... Read more

October 7, 2019 Clinical Research/Diagn. Environ, Ag./Food & Bev Life Science Tools M&A, Partnerships

QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

San Diego, California, Hilden, Germany and Germantown, Maryland – October 7, 2019 – Illumina, Inc. (NASDAQ: ILMN) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a 15-year partnership intended to broaden the availability and use of NGS-based in-vitro diagnostic (IVD) kits, including companion diagnostics, for patient management. The agreement grants QIAGEN non-exclusive... Read more